THNR
Amplify Weight Loss Drug & Treatment ETF
1W: -4.4%
1M: -9.0%
3M: -7.5%
YTD: -3.4%
1Y: -0.2%
$24.56
-0.13 (-0.54%)
Weekly Expected Move ±2.8%
$23
$24
$25
$25
$26
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Portfolio Health Summary
IS Overall Score
60.7
★★★★★
Altman Z-Score
7.77
Safe
Weight Coverage
93%
of portfolio analyzed
Holdings Matched
18
with fundamental data
InsiderStreet Scorecard
★★★★★
60.7
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
7.77
Safe Zone (>2.99)
Piotroski F-Score
6.0 / 9
Moderate
Beneish M-Score
-0.18
Possible Manipulator
Credit Score
—
Earnings Quality
57.7 / 100
Portfolio Valuation
P/E
20.40x
P/B
5.04x
P/S
5.11x
EV/EBITDA
14.31x
EV/Revenue
5.63x
P/FCF
24.04x
P/OCF
17.77x
PEG
1.17x
Earnings Yield
4.90%
FCF Yield
4.16%
OCF Yield
5.63%
Median P/E
21.78x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+16.2%
Net Income
+7.9%
EPS
+16.6%
FCF
+38.5%
EBITDA
+9.6%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+34.4%
Rev CAGR 5Y
+18.2%
EPS CAGR 3Y
+17.5%
EPS CAGR 5Y
+16.9%
FCF CAGR 3Y
+21.8%
FCF CAGR 5Y
+14.0%
EBITDA CAGR 3Y
+12.3%
EBITDA CAGR 5Y
+11.8%
Payout Ratio
74.92%
Buyback Yield
0.64%
Dividend Yield
2.01%
Total Shareholder Return
1.38%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 594 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$24.56
Median 1Y
$23.86
5th Pctile
$17.19
95th Pctile
$33.21
Ann. Volatility
19.4%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 20.40 |
| Portfolio P/B | 5.04 |
| Portfolio P/S | 5.11 |
| EV/EBITDA | 14.31 |
| EV/Revenue | 5.63 |
| P/FCF | 24.04 |
| P/OCF | 17.77 |
| PEG | 1.17 |
| Earnings Yield | 4.90% |
| FCF Yield | 4.16% |
| OCF Yield | 5.63% |
| Median P/E | 21.78 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 71.11% |
| Operating Margin | 33.45% |
| Net Margin | 24.92% |
| FCF Margin | 21.18% |
| ROE | 25.88% |
| ROA | 15.39% |
| ROIC | 28.16% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 0.28 |
| Debt/Assets | 0.16 |
| Net Debt/EBITDA | -0.27 |
| Interest Coverage | 28.13 |
| Current Ratio | 2.06 |
| Quick Ratio | 1.57 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 16.25% |
| Net Income Growth | 7.94% |
| EPS Growth | 16.64% |
| FCF Growth | 38.45% |
| EBITDA Growth | 9.60% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 34.44% |
| Revenue CAGR 5Y | 18.22% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 17.50% |
| EPS CAGR 5Y | 16.93% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 21.75% |
| FCF CAGR 5Y | 13.97% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 12.31% |
| EBITDA CAGR 5Y | 11.79% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 13.97% |
| Net Income CAGR 5Y | 15.40% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 60.7 |
| IS Profitability | 74.0 |
| IS Balance Sheet | 60.8 |
| IS Earnings Quality | 57.7 |
| IS Growth | 53.9 |
| IS Value | 44.0 |
| IS Momentum | 71.7 |
| IS Safety | 86.2 |
| IS Quality | 73.7 |
| Altman Z-Score | 7.77 |
| Piotroski F-Score | 6.04 |
| Beneish M-Score | -0.18 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 2.01% |
| Payout Ratio | 74.92% |
| Buyback Yield | 0.64% |
| Total Shareholder Return | 1.38% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.800 |
| Earnings Stability | 0.589 |
| Earnings Persistence | 0.655 |
| Margin Stability | 0.837 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | 21.78 |
| Median P/B | 4.94 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 92.72% |
| Holdings Matched | 18 |
| Total Holdings | 21 |